Evaluation of efficacy and safety of gefitinib as monotherapy in Chinese patients with advanced non-small cell lung cancer and very poor performance status

por Wei, Zhong, Mengzhao, Wang, Li, Zhang, Longyun, Li, Xiaotong, Zhang
Publicado 2008

Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study

por Jun, Ni, Hanping, Wang, Xiaoyan, Si, Yan, Xu, Mengzhao, Wang, Xiaotong, Zhang, Li, Zhang
Publicado 2020